何氏眼科
(301103)
| 流通市值:18.67亿 | | | 总市值:24.26亿 |
| 流通股本:1.22亿 | | | 总股本:1.58亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 884,568,226.74 | 585,092,897.33 | 305,184,437.79 | 1,092,618,730.41 |
| 营业总成本 | 814,979,531.55 | 534,045,393.17 | 265,692,066.29 | 1,048,951,940.54 |
| 其他经营收益 | | | | |
| 营业利润 | 81,086,935.18 | 58,799,660.7 | 42,210,252.36 | 58,152,204.65 |
| 利润总额 | 78,548,458.51 | 57,597,874.47 | 41,608,676.47 | 56,034,775.92 |
| 净利润 | 53,694,354.06 | 41,385,282.65 | 32,611,617.14 | 26,404,935.55 |
| 每股收益 | | | | |
| 其他综合收益 | -9,526.59 | 10,824.07 | -7,446.42 | 3,785.21 |
| 综合收益总额 | 53,684,827.47 | 41,396,106.72 | 32,604,170.72 | 26,408,720.76 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 1,545,716,183.57 | 1,481,753,597.8 | 1,494,633,116.18 | 1,472,807,168.24 |
| 非流动资产: | | | | |
| 非流动资产合计 | 703,039,510.78 | 719,313,251.87 | 737,545,562.48 | 708,973,805.56 |
| 资产总计 | 2,248,755,694.35 | 2,201,066,849.67 | 2,232,178,678.66 | 2,181,780,973.8 |
| 流动负债: | | | | |
| 流动负债合计 | 185,226,785.3 | 158,348,510.35 | 175,353,334.8 | 163,811,498.68 |
| 非流动负债: | | | | |
| 非流动负债合计 | 136,561,319.64 | 132,128,905.65 | 135,821,718.14 | 133,659,454.75 |
| 负债合计 | 321,788,104.94 | 290,477,416 | 311,175,052.94 | 297,470,953.43 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,926,693,606.5 | 1,910,240,563.11 | 1,920,583,907.54 | 1,883,813,108.81 |
| 股东权益合计 | 1,926,967,589.41 | 1,910,589,433.67 | 1,921,003,625.72 | 1,884,310,020.37 |
| 负债和股东权益合计 | 2,248,755,694.35 | 2,201,066,849.67 | 2,232,178,678.66 | 2,181,780,973.8 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 955,456,710.9 | 627,965,910.31 | 326,997,710.97 | 1,180,990,536.69 |
| 经营活动现金流出小计 | 779,782,804.52 | 529,260,051.13 | 250,921,968.19 | 1,024,056,043.01 |
| 经营活动产生的现金流量净额 | 175,673,906.38 | 98,705,859.18 | 76,075,742.78 | 156,934,493.68 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 2,462,320,820.03 | 1,460,371,097.7 | 379,347,402.58 | 3,214,305,510.2 |
| 投资活动现金流出小计 | 2,732,071,119 | 1,685,230,111 | 618,803,257.98 | 3,524,749,452.93 |
| 投资活动产生的现金流量净额 | -269,750,298.97 | -224,859,013.3 | -239,455,855.4 | -310,443,942.73 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | - | - | - | 240,000 |
| 筹资活动现金流出小计 | 57,790,861.25 | 45,929,616.27 | 11,005,878.54 | 73,871,352.62 |
| 筹资活动产生的现金流量净额 | -57,790,861.25 | -45,929,616.27 | -11,005,878.54 | -73,631,352.62 |
| 汇率变动对现金及现金等价物的影响 | 32,806.73 | 6,474.62 | 9,107.1 | 748.9 |
| 现金及现金等价物净增加额 | -151,834,447.11 | -172,076,295.77 | -174,376,884.06 | -227,140,052.77 |
| 期末现金及现金等价物余额 | 387,054,001.87 | 366,812,153.21 | 364,511,564.92 | 538,888,448.98 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -172,076,295.77 | - | -227,140,052.77 |